17.16 USD
↘ 0.83 (4.61%)AT CLOSE (11:59 AM EDT)
NovoCure Limited Ordinary Shares
NVCRNASDAQ • USD
17.17
↗ 0.01 (0.06%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
17.17
↗ 0.01 (0.06%)
Market: CLOSED
Open?$17.60
High?$17.97
Low?$17.00
Prev. Close?$17.99
Volume?2.2M
Avg. Volume?1.8M
VWAP?$17.42
Rel. Volume?1.17x
Bid / Ask
Bid?$15.85 × 100
Ask?$17.67 × 700
Spread?$1.82
Midpoint?$16.76
Valuation & Ratios
Market Cap?2.0B
Shares Out?115.8M
Float?105.2M
Float %?90.8%
P/E Ratio?N/A
P/B Ratio?6.01
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
NVCR is currently priced at $17.16. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place NVCR at a fair price relative to peers.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Themes
Employees
1.6K
Market Cap
2.0B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2015-10-02
Address
NO. 4 THE FORUM
ST. HELIER,
Phone: 44 (0)15 3475 6700
ST. HELIER,
Phone: 44 (0)15 3475 6700
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?9
Momentum?60
Short Sent.?50
Piotroski F-Score?3/9Weak
Altman Z-Score?0.89Distress
Confidence?62%Moderate
Short InterestElevated
Short % of Float?8.12%Elevated
Short Interest?8.5M
Days to Cover?4.3
Free Float105.2M
Avg Daily Volume2.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.86Strong
Quick Ratio?2.66Strong
Cash Ratio?0.40Low
Debt/Equity?0.59Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.01FAIR▾
Peers100
S&P31
P/S?2.95CHEAP▾
Peers100
S&P51
P/FCF?N/A▾
EV/EBITDA?-12.5CHEAP▾
S&P97
EV/Sales?3.11FAIR▾
Peers100
S&P59
Returns & Efficiency
ROE?-52.3%WEAK▾
S&P3
ROA?-22.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-48072000
Enterprise Value?$2.1B
Fundamentals ratios updated end of day